NY Post : Family says dad killed mom because he got too high on weed candy

DENVER — The family of three boys filed a lawsuit against two recreational marijuana businesses after a shooting that left their mother dead and their father charged with murder.

The lawsuit claims companies that made a type of marijuana-infused candy and sold it to the father failed to warn him about its potency and possible side effects, including psychotic behavior.

The Denver Post reported Tuesday the suit was filed on the boys’ behalf by their grandparents, Wayne and Marti Kohnke, and aunt, Tamara Heman, who are now their guardians.

Richard Kirk is charged with first-degree murder in the April 14, 2014, shooting death of his wife, Kristine Kirk. Before she was shot, Kristine Kirk told a 911 dispatcher her husband was hallucinating and was getting a gun.

Richard Kirk pleaded not guilty by reason of insanity. A defense expert, Dr. Andrew Monte, said in a report submitted to the court that Kirk was intoxicated with THC, marijuana’s psychoactive ingredient, which led to delirium.

Authorities said low levels of THC were found in his blood, and a partially eaten piece of marijuana candy was found in the house. The candy came from a legal marijuana shop.

The lawsuit names Gaia’s Garden LLC and Nutritional Elements Inc. It says Gaia’s Garden made the candy and that Kirk bought it from Nutritional Elements.

Sean McAllister, an attorney for Gaia’s Garden, said the company has always complied with state requirements for labeling and packaging its products. He said marijuana doesn’t lead to violence and that the company will fight the suit.

Tiffany Goldman, chief operating officer for Nutritional Elements, declined to comment.

(MS) MNST / STZ / NWL : New Comp. Accounting rule positive for these names

Morgan Stanley making positive comments on MNST, STZ, NWL citing new stock compensation accounting rule 
- The FASB recently issued a new standard (ASU 2016-09) requiring all excess tax benefits, or 'windfall' tax deductions, to be recognized in income and presented as operating cash flows (see below for a list of companies that have already reflected this change in accounting method). To put it simply, companies who issue share-based compensation (options/restricted stock/etc) will be required to account for any tax impact above (or below) what was originally expected when the compensation was granted. Said another way, an excess tax benefit (or deficiency) arises when a company takes an actual tax deduction that is greater (or less) than the deduction that was expected when the corresponding share-based awards were granted. 
- For instance, take an award valued at $100 on the grant date that vests over 2 years. The company expects a tax deduction at the grant date of $35, based on a 35% tax rate. If the underlying award is valued at $200 after vesting, then the actual tax deduction is $70 ($200 x 35%), resulting in an 'excess' benefit of $35.

>>> Macy's beats by $0.02, misses on revs; lowers FY17 EPS and sales guidance; r

Macy's beats by $0.02, misses on revs; lowers FY17 EPS and sales guidance; raises quarterly dividend 4.9% to $0.3775
  • Reports Q1 (Apr) earnings of $0.40 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus of $0.38; revenues fell 7.4% year/year to $5.77 bln vs the $5.94 bln Capital IQ Consensus. The year-over-year decline in total sales reflects, in part, the 41 stores closed in 2015.
    • Comparable sales on an owned plus licensed basis were down by 5.6 percent in the first quarter. On an owned basis, first quarter comparable sales declined by 6.1 percent.
  • Co issues downside guidance for FY17, sees EPS of $3.15-3.40 vs. $3.78 Capital IQ Consensus Estimate; sees FY17 revs of below down 2% to ~$26.54 bln vs. $26.51 bln Capital IQ Consensus Estimate.
    • Noting that the uncertain direction of consumer spending makes predictions of future performance difficult, Macy's, Inc. now expects full-year 2016 comparable sales on an owned plus licensed basis to decrease in the range of 3-4%, with comparable sales on an owned basis to be ~50 basis points lower. This compares with previous guidance for comparable sales on an owned plus licensed basis to decline by approximately 1 percent in fiscal 2016.
  • "We are seeing continued weakness in consumer spending levels for apparel and related categories. In particular, our sales trend relative to expectations meaningfully slowed beginning in mid-March, and first quarter results are below our original outlook. Headwinds also are coming from a second consecutive year of double-digit spending reductions by international visitors in major tourist markets where Macy's and Bloomingdale's are key destinations, as well as a slowdown in some center core categories -- further intensifying the challenges associated with growing topline sales revenue."
  • Macy's, Inc.'s board of directors has authorized an increase in the quarterly dividend on Macy's common stock to 37.75 cents per share from the current 36 cents per share.
  • Related stocks to watch: Upcoming department store earnings releases include Kohl's (KSS) reports earnings May 12 before the open, Nordstrom (JWN) May 12 after the close, JC Penney (JCP) May 13 before the open, Sears (SHLD) early June.

>>> Macy's sinks following earnings report, with guidance cut even worse than fe

Macy's sinks following earnings report, with guidance cut even worse than feared; M now -7% in pre-market at 34.25
  • This follows disappointing Gap (GPS) earnings/guidance yesterday.
  • Related stocks to watch: Upcoming Department Store Earnings Releases: Kohl's (KSS) reports earnings May 12 before the open, Nordstrom (JWN) May 12 after the close, JC Penney (JCP) May 13 before the open, Sears (SHLD) early Jun

>>> US Early premarket gappers

Early premarket gappers

Gapping up: WYY +19.5%, FUEL +17.1%, GAIA +17%, TROV +16.7%, NAII +15.1%, CDOR +13.9%, NTRA +13.6%, TWER +12.4%, CTIC +10.7%, CSIQ +10.6%, HEAR +10%, AG +7.2%, KTCC +7.1%, EA +6.9%, RICK +6.4%, CVM +5.3%, ELMD +5%, REXX +4.8%, SGYP +4.8%, MTBC +4.4%, AUY +4.3%, BUFF +4.1%, MUX +4%, SQBG +3.6%, ALB +3.1%, EGO +2.9%, PLNT +2.9%, MTL +2.6%, SLW +2.6%, KGC +2.5%, VKTX +2.4%, SLV +2.3%, GDX +2.3%, NEM +2.3%, FCX +2.2%, IAG +2.2%, ABX +2%, CALL +1.9%, JKS +1.8%, SYNC +1.6%, VTAE +1.5%, AU +1.4%, SBGL +1.2%, CHK +1.2%, CSLT +1.2%, WFT +1.1%, ISR +1%, JIVE +1%, GLD +0.8%

Gapping down: ODP -36.1%, FOSL -30.8%, CJES -29.9%, TRXC -16%, QTM -13.7%, SPLS -13.6%, FELP -11.6%, ZAGG -10.1%, WATT -8.7%, RENN -8.1%, FOGO -6.9%, NUAN -5.5%, CS -5.3%, ALRM -4.9%, DIS -4.8%, ARWR -4.7%, MOMO -4.4%, AMBC -4.2%, DANG -4.1%, ERF -3.5%, XONE -3.4%, HPP -3.2%, ATSG -3.2%, DGLY -3.1%, YY -3%, DB -3%, WGBS -3%, NAME -2.8%, M -2.7%, TM -2.6%, MTSC -2.6%, SAN -2.4%, LRAD -2.4%, CYTX -2.3%, LPI -2%, BCS -1.8%, HSBC -1.5%, HLIT -1.5%, AXAS -1.5%, NATR -1.4%, TOT -1.3%, SDRL -1.3%, AMRS -1.3%, ED -1.2%, JAZZ -1.2%, ZIOP -1.1%, ING -1%, ECPG -1%

>>> Statement on EU Commission blocking Three / O2 merger

Statement on EU Commission blocking Three / O2 merger


Dido Harding, CEO of TalkTalk said: “This is the right outcome for UK mobile customers. We were always clear that going from four mobile networks to three would have meant higher prices and less competition, so it’s reassuring to see competition regulators standing firmly on the side of consumers. We have long argued, as the Commission have again this morning, that innovation and improvement in service quality stems from more competition, not less. We hope that the UK regulators will take an equally robust approach to the significant competition issues that have been identified here around the future of Openreach.”

WSJ : An Investment Banker’s Worst Nightmare

An Investment Banker’s Worst Nightmare

More companies are deciding to do without bankers when they make acquisitions

One day late last month, two big companies announced takeovers that had something in common: Neither Comcast Corp. nor AbbVie Inc. used a banker.

Comcast and AbbVie, both giants in corporate America, aren’t alone. More companies are deciding to do without bankers when they make acquisitions.

In 2015, the buyers in public-company deals valued at more than $1 billion didn’t use financial advisers in 70 instances, or 26% of the time, according to Dealogic. That is the second-highest total on record and far surpasses the 25 cases, or 13% share, in 2014.

In 2016, there have already been 23 examples, or 27% of deals in question. While merger volume has been surging, the rise in deals without a bank since 2014 is more pronounced.

That is bad news for Wall Street firms, which bring in enormous fees—sometimes measuring in the tens or even hundreds of millions of dollars—from takeover advice. The timing could hardly be worse for big banks as they lose market share to smaller upstarts known as boutiques and grapple with new regulations and low interest rates.

Boutique firms such as Moelis & Co. and Perella Weinberg Partners LP have steadily gained ground on their larger rivals in recent years, with the group’s market share based on fees recently at nearly 18% so far in 2016, more than double where it stood in 2008, according to Dealogic.

Corporate executives attribute the rise to a desire to keep transactions confidential, move quickly when needed and, of course, save money. There is also a view by some that all bankers don’t always have their best interests at heart.

In his 2014 letter to shareholders of Berkshire Hathaway Inc., Warren Buffett captured that view. He derided investment bankers, who, “being paid as they are for action, constantly urge acquirers to pay 20% to 50% premiums over market price for publicly-held businesses.” He went on: “A few years later, bankers—bearing straight faces—again appear and just as earnestly urge spinning off the earlier acquisition in order to ‘unlock shareholder value.’”

What has changed inside companies?

Some of them now have large internal teams capable of developing deal strategy, building out financial models and executing transactions without bankers’ help.

The trend has accelerated as companies again embrace M&A after years of sluggish activity. Meanwhile, restrictions on compensation and other regulations at big banks have created a steady supply of seasoned advisers willing to go in-house—even if the pay is lower.

Making such a move generally involves taking a pay cut. Senior internal deal makers at big companies often rake in more than $1 million a year, and such roles can be stepping stones to bigger jobs like finance chief. But in a good year, a senior M&A banker can make several million dollars.

In one previously unreported recent move, Goldman Sachs Group Inc. media banker Guy Nachtomi left to join Activision Blizzard Inc. as chief strategy officer, people familiar with the matter said.

Banks haven’t disappeared completely, of course.

Big Wall Street firms have armies of advisers with wide-ranging expertise and access to valuable information. Having bankers can also inoculate deals against legal challenges if they are botched or the price is questioned. And companies often need to borrow for takeovers, which frequently goes hand in hand with advice.

It is especially difficult for a company on the sell side of a transaction to go it alone, deal makers say. Coordinating a multilayered auction without a banker, for example, would be challenging and expose the company to legal risk.

None of that deterred Comcast or AbbVie, both of which recently hired ex-bankers.

Comcast brought on Bob Eatroff from Morgan Stanley as executive vice president of global corporate development and strategy.

When Comcast agreed to buy DreamWorks Animation SKG for $3.8 billion last month, the cable company handled the negotiations itself in part because it needed to move quickly, said people familiar with the matter. Over the course of two weeks, Comcast’s deal team and executives including Chief Financial Officer Mike Cavanagh—a former banker—hammered out an agreement with the film studio, the people said.

Toward the end of the talks, Comcast’s board had a few phone calls with Paul Taubman of boutique PJT Partners Inc. to get an outside opinion, some of the people said.

PJT will likely get less than the typical outside-adviser fee on such a deal of as much as $20 million, one of the people said.

AbbVie also eschewed an investment bank when it agreed that April day to buy cancer-drug developer Stemcentrx for $5.8 billion.

The drug company in December hired J.P. Morgan Chase & Co.’s Henry Gosebruch to be chief strategy officer.

Within Mr. Gosebruch’s first two weeks on the job, AbbVie set up a meeting with Stemcentrx’s chief executive and indicated interest in buying the company, said a person familiar with the matter. By the time an auction for Stemcentrx later began, AbbVie had already done a substantial amount of work and didn’t see the need to bring in a bank, the person said.

As AbbVie finalized the purchase, it tapped Bank of America Corp. —for a fairness opinion, which typically costs much less.

Neither PJT nor Bank of America was credited for advising in press releases announcing the two deals.